PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Klin Padiatr 2022; 234(03): 169-171
DOI: 10.1055/a-1699-3016
Short Communication

Secondary Biphenotypic Acute Leukemia Following Rosai-Dorfman-Disease A Coincidence?

Sekundäre biphänotypische akute Leukämie nach Rosai-Dorfmann-Erkrankung – eine Ko-Inzidenz?

Authors

  • Anne Thieme

    1   Department of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany

  • Katja Maurus

    2   Department of Pathology, University of Würzburg, Wuerzburg, Germany

  • Karen Ernestus

    2   Department of Pathology, University of Würzburg, Wuerzburg, Germany

  • Steffen Hirsch

    3   Hopp Children’s Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ) University Hospital Heidelberg, University Hospital Heidelberg Medical Clinic, Heidelberg, Germany

  • Kathrin Schramm

    3   Hopp Children’s Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ) University Hospital Heidelberg, University Hospital Heidelberg Medical Clinic, Heidelberg, Germany

  • Clemens Wirth

    4   Institute of Radiology, University Hospital Würzburg, Würzburg, Germany

  • Andreas Buck

    5   Department of Nuclear Medicine, University of Würzburg, Wuerzburg, Germany

  • Christoph Härtel

    6   Pediatric, Klinikum der Universität Würzburg, Wurzburg, Germany

  • Paul G. Schlegel

    7   Childrens Hospitals, University of Würzburg, 97080, Germany

  • Matthias Eyrich

    1   Department of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany

  • Mathias Woelfl

    8   Department of pediatric hemato-oncology, University Clinic of Würzburg, Wuerzburg, Germany

  • Carl Friedrich Classen

    9   Pediatric Oncology and Hematology, University Children’s Hospital Rostock, Rostock, Germany

  • Verena A. Wiegering

    1   Department of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints
Preview
Abbreviations

RDD Rosai-Dorfman-Disease

TP53 Tumor protein p53

CNS Central nervous system

Dexa dexamethasone

ESR Erythrocyte sedimentation rate

IC-2 Initial Course 2 of LCH-registry Therapy (Vinblastine and Prednisolone)LCH-registry International Collaborative TreatmentProtocol for Children and Adolescents with Langerhans Cell Histiocytosis

LDH Lactate dehydrogenase

MRD Minimal residual disease

MRI Magnetic resonance imaging

N-LCH Non-Langerhans cell histiocytosis

Nel Nelarabine

Cyt Cytarabine

Eto Etoposide

Dara Daratumomab



Publikationsverlauf

Artikel online veröffentlicht:
15. Dezember 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany